Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 2/20 | 0.56 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.56 |
| ▸ | NR3C1 | P04150 | 14/20 | 0.49 |
| ▸ | PGR | P06401 | 1/20 | 0.46 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.46 |
| ▸ | AR | P10275 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4624216 | 0.85 | KEAP1 (0.46) | KEAP1NFE2L2NR3C1PGRNR3C2 | |
| SCHEMBL13869170 | 0.82 | KEAP1 (0.65) | KEAP1NFE2L2NR3C1PGRNR3C2 | |
| SCHEMBL2564270 | 0.79 | KEAP1 (0.38) | KEAP1NFE2L2NR3C1PGRNR3C2 | |
| SCHEMBL21931626 | 0.78 | KEAP1 (0.59) | KEAP1NFE2L2NR3C1PGRNR3C2 | |
| SCHEMBL28380698 | 0.77 | ALDH1A1 (0.45) | ALDH1A1 | |
| SCHEMBL14092111 | 0.77 | NR3C1 (0.39) | KEAP1NFE2L2NR3C1ALDH1A1 | |
| SCHEMBL5201346 | 0.76 | KEAP1 (0.57) | KEAP1NFE2L2NR3C1PGRNR3C2 | |
| SCHEMBL5203771 | 0.75 | KEAP1 (0.51) | KEAP1NFE2L2NR3C1PGRNR3C2 | |
| SCHEMBL15108064 | 0.72 | KEAP1 (1.00) | KEAP1NFE2L2NR3C1PGRNR3C2 | |
| SCHEMBL5318130 | 0.71 | HSD17B10 (0.51) | TP53ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0887346-B1 | N-Phenyl-alkylsulfonamide derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists | HOFFMANN LA ROCHE (CH) | 2007-12-12 | — | — | EP | disclosed |
| US-6057349-A | ALPHA.SUB.1A/1L AGONISTS USED IN THE TREATMENT OF VARIOUS DISEASE STATES SUCH AS URINARY INCONTINENCE, NASAL CONGESTION, PRIAPISM, DEPRESSION, ANXIETY, DEMENTIA, SENILITY, ALZHEIMER'S, DEFICIENCIES IN ATTENTIVENESS AND COGNITION, AND | F. HOFFMAN LA ROCHE AG (CH) | 2000-05-02 | — | — | US | disclosed |
| US-5952362-A | INHIBITOR OF GLYCOGEN PHOSPHORYLASE ENZYMETIC ACTIVITY AND GLUCOSE ACITIVITY | SYNTEX (U.S.A) INC. (US) | 1999-09-14 | — | — | US | disclosed |
| EP-0887346-A2 | Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists | F. HOFFMANN-LA ROCHE AG (CH) | 1998-12-30 | — | — | EP | disclosed |